Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain

NCT06797817 is registered in ClinicalTrials.gov with Universidad de Almeria as lead sponsor.

NCT NCT06797817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06797817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain
Lead sponsor
Universidad de Almeria
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
September 2, 2029
Enrollment
156 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad)